262 related articles for article (PubMed ID: 22058206)
1. Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study.
Pidala J; Vogelsang G; Martin P; Chai X; Storer B; Pavletic S; Weisdorf DJ; Jagasia M; Cutler C; Palmer J; Jacobsohn D; Arai S; Lee SJ
Haematologica; 2012 Mar; 97(3):451-8. PubMed ID: 22058206
[TBL] [Abstract][Full Text] [Related]
2. The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality.
Pidala J; Kim J; Anasetti C; Nishihori T; Betts B; Field T; Perkins J
Haematologica; 2011 Nov; 96(11):1678-84. PubMed ID: 21791465
[TBL] [Abstract][Full Text] [Related]
3. Analysis of gastrointestinal and hepatic chronic graft-versus-host [corrected] disease manifestations on major outcomes: a chronic graft-versus-host [corrected] disease consortium study.
Pidala J; Chai X; Kurland BF; Inamoto Y; Flowers ME; Palmer J; Khera N; Jagasia M; Cutler C; Arora M; Vogelsang G; Lee SJ
Biol Blood Marrow Transplant; 2013 May; 19(5):784-91. PubMed ID: 23395601
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium.
Pidala J; Kurland BF; Chai X; Vogelsang G; Weisdorf DJ; Pavletic S; Cutler C; Majhail N; Lee SJ
Haematologica; 2011 Oct; 96(10):1528-35. PubMed ID: 21685473
[TBL] [Abstract][Full Text] [Related]
5. Hand grip strength and 2-minute walk test in chronic graft-versus-host disease assessment: analysis from the Chronic GVHD Consortium.
Pidala J; Chai X; Martin P; Inamoto Y; Cutler C; Palmer J; Weisdorf D; Pavletic S; Arora M; Jagasia M; Jacobsohn D; Lee SJ
Biol Blood Marrow Transplant; 2013 Jun; 19(6):967-72. PubMed ID: 23542686
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of prognostic factors among patients with chronic graft-versus-host disease.
Pérez-Simón JA; Afram G; Martino R; Piñana JL; Caballero-Velazquez T; Ringden O; Valcarcel D; Caballero D; Remberger M; de Paz Y; Sierra J; Miguel JS; Hagglund H
Haematologica; 2012 Aug; 97(8):1187-95. PubMed ID: 22371184
[TBL] [Abstract][Full Text] [Related]
7. Response and survival of patients with chronic graft-versus-host disease treated by extracorporeal photochemotherapy: a retrospective study according to classical and National Institutes of Health classifications.
Del Fante C; Scudeller L; Viarengo G; Bernasconi P; Perotti C
Transfusion; 2012 Sep; 52(9):2007-15. PubMed ID: 22320219
[TBL] [Abstract][Full Text] [Related]
8. National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis.
Baird K; Steinberg SM; Grkovic L; Pulanic D; Cowen EW; Mitchell SA; Williams KM; Datiles MB; Bishop R; Bassim CW; Mays JW; Edwards D; Cole K; Avila DN; Taylor T; Urban A; Joe GO; Comis LE; Berger A; Stratton P; Zhang D; Shelhamer JH; Gea-Banacloche JC; Sportes C; Fowler DH; Gress RE; Pavletic SZ
Biol Blood Marrow Transplant; 2013 Apr; 19(4):632-9. PubMed ID: 23340040
[TBL] [Abstract][Full Text] [Related]
9. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria.
Jagasia M; Giglia J; Chinratanalab W; Dixon S; Chen H; Frangoul H; Engelhardt B; Goodman S; Greer J; Kassim A; Morgan D; Ruffner K; Schuening F
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1207-15. PubMed ID: 17889358
[TBL] [Abstract][Full Text] [Related]
10. Graft-versus-tumor effect according to type of graft-versus-host disease defined by National Institutes of Health consensus criteria and associated outcomes.
Cho BS; Lee SE; Song HH; Lee JH; Yahng SA; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Biol Blood Marrow Transplant; 2012 Jul; 18(7):1136-43. PubMed ID: 22261380
[TBL] [Abstract][Full Text] [Related]
11. Quality of Life in the Chronic GVHD Consortium Cohort: Lessons Learned and the Long Road Ahead.
Krupski C; Jagasia M
Curr Hematol Malig Rep; 2015 Sep; 10(3):183-91. PubMed ID: 26303672
[TBL] [Abstract][Full Text] [Related]
12. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
[TBL] [Abstract][Full Text] [Related]
13. Impact of Psychological Distress on Quality of Life, Functional Status, and Survival in Patients with Chronic Graft-versus-Host Disease.
El-Jawahri A; Pidala J; Khera N; Wood WA; Arora M; Carpenter PA; Palmer J; Flowers ME; Jagasia M; Chen YB; Lee SJ
Biol Blood Marrow Transplant; 2018 Nov; 24(11):2285-2292. PubMed ID: 30031937
[TBL] [Abstract][Full Text] [Related]
14. [Effects of chemotherapy combined with donor lymphocyte infusion on chronic graft-versus-host disease and prognosis in minimal residual disease positive patients after allogeneic hematopoietic stem cell transplantation].
Shi YX; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YY; Liu KY; Huang XJ; Mo XD
Zhonghua Xue Ye Xue Za Zhi; 2019 Sep; 40(9):713-719. PubMed ID: 31648470
[No Abstract] [Full Text] [Related]
15. Patient-reported outcomes and health status associated with chronic graft-
Lee SJ; Onstad L; Chow EJ; Shaw BE; Jim HSL; Syrjala KL; Baker KS; Buckley S; Flowers ME
Haematologica; 2018 Sep; 103(9):1535-1541. PubMed ID: 29858386
[TBL] [Abstract][Full Text] [Related]
16. Failure-free survival in a prospective cohort of patients with chronic graft-versus-host disease.
Palmer J; Chai X; Martin PJ; Weisdorf D; Inamoto Y; Pidala J; Jagasia M; Pavletic S; Cutler C; Vogelsang G; Arai S; Flowers ME; Lee SJ
Haematologica; 2015 May; 100(5):690-5. PubMed ID: 25715403
[TBL] [Abstract][Full Text] [Related]
17. Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.
Inamoto Y; Kimura F; Kanda J; Sugita J; Ikegame K; Nakasone H; Nannya Y; Uchida N; Fukuda T; Yoshioka K; Ozawa Y; Kawano I; Atsuta Y; Kato K; Ichinohe T; Inoue M; Teshima T;
Haematologica; 2016 Dec; 101(12):1592-1602. PubMed ID: 27662017
[TBL] [Abstract][Full Text] [Related]
18. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
Savani BN; Labopin M; Blaise D; Niederwieser D; Ciceri F; Ganser A; Arnold R; Afanasyev B; Vigouroux S; Milpied N; Hallek M; Cornelissen JJ; Schwerdtfeger R; Polge E; Baron F; Esteve J; Gorin NC; Schmid C; Giebel S; Mohty M; Nagler A
Haematologica; 2016 Feb; 101(2):256-62. PubMed ID: 26565001
[TBL] [Abstract][Full Text] [Related]
19. Clinical benefit of response in chronic graft-versus-host disease.
Inamoto Y; Martin PJ; Chai X; Jagasia M; Palmer J; Pidala J; Cutler C; Pavletic SZ; Arora M; Jacobsohn D; Carpenter PA; Flowers ME; Khera N; Vogelsang GB; Weisdorf D; Storer BE; Lee SJ;
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1517-24. PubMed ID: 22683612
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of NIH consensus criteria for chronic graft-versus-host disease.
Cho BS; Min CK; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Kim CC
Leukemia; 2009 Jan; 23(1):78-84. PubMed ID: 18830253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]